66 episodes
Treating Blood Cancers The Leukemia & Lymphoma Society
-
- Science
Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.
-
Insights and Updates on Navigating the AML Landscape
Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX
Recorded on March 28, 2024
Hagop M. Kantarjian, M.D.
Professor and Chairman, Department of Leukemia
Samsung Distinguished University Chair in Cancer Medicine
MD Anderson Cancer Center, University of Texas
Houston, TX
Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care.
Learn more today! -
CAR T-cell Therapy in 2024
Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO
Recorded on March 12, 2024
Michael Tees, MD, MPH
Director, Lymphoma Program
Lymphoma Executive Committee Member, Sarah Cannon Research Institute
Associate Member, Colorado Blood Cancer Institute
Denver, CO
Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses
Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to discuss treatment options with your patients, what to consider when referring patients for CAR T-cell therapy, how to prepare patients, and educating patients and caregivers about toxicity management. He also provides insight into the limitations of CAR-T therapy, as well as future directions. Tune in to this informative episode today to learn more!
This episode is supported by Bristol Myers Squibb, Johnson & Johnson|Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation. -
Supporting Healthcare Professionals to Reduce Burnout
Alfred Lee, MD, PhD, Yale University, New Haven, CT
Recorded on February 22, 2024
Alfred Lee, MD, PhD
Professor of Medicine, Yale School of Medicine
Program Director, Hematology and Medical Oncology Fellowship
Chief, Division of Classical Hematology, Yale Cancer Center
Yale University
New Haven, CT
Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in healthcare professionals. While reflecting on his personal experience, Dr. Lee discusses warning signs, symptoms, risk factors, and strategies and resources to help reduce and prevent burnout. Tune in today! -
Creating a Roadmap for Adult Survivorship Care
Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL
Recorded on December 7, 2023
Meghna Ailawadhi, M.B.B.S., M.D.
Cancer Survivorship Consultant, Assistant Professor of Medicine
Department of Hematology/Oncology
Mayo Clinic
Jacksonville, FL
In this episode, Dr. Meghna Ailawadhi from the Mayo Clinic in Jacksonville, FL joins us for a conversation on survivorship care for adults. Dr. Ailawadhi discusses the importance of shared decision-making and coordination with primary care, including strategies to support adherence. She also provides an overview of disparities and challenges in survivorship care, as well as education and support resources for healthcare professionals and survivors. Learn more by listening today!
This episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc. -
Highlights from attending the 2023 ASH Annual Meeting
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Recorded on December 19, 2023
Lee Greenberger, PhD
Chief Scientific Officer and SVP
The Leukemia & Lymphoma Society
Rye Brook, NY
Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to discuss highlights from the 65th American Society of Hematology (ASH) Annual Meeting in December 2023, including updates on blood cancer research, treatment, and clinical trials in leukemia, lymphoma, myeloma, MDS, and MPNs. Tune in to this informative update today! -
A Conversation on Transplantation
Jeffery Auletta, MD, National Marrow Donor Program® (NMDP)/Be the Match®
Recorded on November 30, 2023
Jeffery Auletta, MD
Senior Vice President, Patient Outcomes and Experience
National Marrow Donor Program® (NMDP)/Be The Match®
Chief Scientific Director
CIBMTR® (Center for International Blood and Marrow Transplant Research®)
National Marrow Donor Program® (NMDP)/Be The Match®
Join us as Dr. Jeffery Auletta from the National Marrow Donor Program® (NMDP)/Be the Match® reflects on the history, advances, and future of transplantation to treat blood cancers. Dr. Auletta also shares insights on disparities and barriers to receiving a transplant, expanding access, and how healthcare professionals can support patients through transplantation. Tune in to this engaging episode today!